Related Experiment Video
Updated: Jun 1, 2026

06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
Circulating tumor DNA in biliary tract cancers: challenges, opportunities, and clinical readiness
Francheska Cadacio1, Anthony Turpin2, Pedro M Rodrigues3
1Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain.
Trends in Cancer
|May 30, 2026
Abstract:
Biliary tract cancers have a poor prognosis, with tumor location and desmoplasia often restricting tissue acquisition for molecular profiling. Circulating tumor DNA is a minimally invasive alternative with expanding clinical utility, although technical and standardization challenges limit its routine adoption. We review evidence, limitations, and strategies supporting large-scale validation for real-time monitoring and personalized treatment.

